Elliott N. Schwartz, M.D., was an Assistant Clinical Professor in the Division of Nephrology and an Attending Physician in the Skeletal Health Service in the Dept of Orthopaedics at the University of California, San Francisco. He was the founder and Institute Director of the Northern California Institute for Bone Health, Inc., in Orinda, a 501 (c) (3) non-profit foundation, and has a private practice in Internal Medicine, Nephrology and Metabolic Bone Disease. He was Board Certified in Internal Medicine and Nephrology (1994-2004) and was board eligible in pathology. He had worked as Team Physician, Internal Medicine, for the Oakland Athletics baseball team and is a Medical Consultant to the Oakland Raiders. He was previously a Team Physician for the Golden State Warriors. He was known especially for his work with elite athletes.
He received his medical degree from the State University of New York, Downstate Medical Center in Brooklyn and completed his internship and residency in internal medicine at Long Island Jewish Medical Center in New Hyde Park, New York. He moved to California to complete a residency in pathology at Stanford University Medical Center in Palo Alto where he also continued with fellowships in surgical pathology and nephrology.
Dr. Schwartz was a member of the American Society for Bone and Mineral Research, the National Osteoporosis Foundation, the International Osteoporosis Foundation, and the International Society for Clinical Densitometry (ISCD) where he taught as faculty for certification courses and helped to develop the facility accreditation program. He was a reviewer for the Journal of Clinical Densitometry and Osteoporosis International.
Dr. Schwartz has been co-investigator on almost 40 clinical trials to study drugs that have been approved for osteoporosis and other indications. He has authored and co-authored publications discussing the detection and diagnosis of osteoporosis as well as provided education on the disorder.
On 7-1-18, he was named a Fellow of the American Society for Bone and Mineral Research “In recognition of his distinguished accomplishments and contributions to the musculoskeletal field, and many years of contributions to the Society.”
In 2010, Dr. Shuhart founded Swedish Bone Health and Osteoporosis Center at Swedish Medical Group in Seattle, Washington. He is Director of the program.
Dr. Shuhart is a member of the Board of Directors of the ISCD since 2015, and former Chair of ISCD’s Facility Accreditation Committee. In 2013, ISCD named Dr. Shuhart “Clinician of the Year.” Dr. Shuhart is current chair for the 2023 ISCD Position Development Conference.
He teaches bone health and osteoporosis to Family Medicine residents and Geriatric Fellows through Swedish’s training programs.
Dr. Shuhart received his medical degree from Dartmouth Medical School in 1987, and completed residency in Family Medicine at Brown University in 1990. In 2009, he was awarded a Master’s in Health Administration from the University of Washington in Seattle.
Dr. Wing P. Chan is Professor and Chief of the Department of Radiology at Wan Fang Hospital, Taipei Medical University, Taiwan. Currently, he is the Taiwan Radiological Society president, Taiwanese Osteoporosis Association honorary consultant, ISCD Asia Pacific Panel chair, Scientific Advisory Council chair, BOD member, and IOF/ISCD Joint Osteoporosis Essentials Course faculty. He earned his medical degree from Taipei Medical University and completed his residency at National Taiwan University Hospital. In 1989 he completed a Musculoskeletal Radiology research fellowship at UCSF and stayed until 1992 as a visiting assistant professor. He subsequently served as a staff radiologist at Sun Yat-Sen Cancer Center in Taiwan. Dr. Chan is a founding convener of the Musculoskeletal Radiology committee, DXA Quality and Osteoporosis Education committee, and Safety and Quality committee of the Taiwan Radiological Society. Dr. Chan implemented a series of strategies to improve osteoporosis detection in Taiwan, finding a prevalence of osteoporosis close to 30% in Taiwanese postmenopausal women. Dr. Chan also established the mandatory DXA and Osteoporosis – Prerequisite Course for Taiwanese Radiology Residency Programs. Further, Dr. Chan developed quality improvement DXA best practices for technologists during scan acquisition and analysis.
He instituted a standardized automated DXA reporting system to reduce reporting errors. In 2013, Dr. Chan was the first physician to receive The National Best Teacher Award from the Ministry of Education in Taiwan. Dr. Chan has served as editor of 7 books and author or co-author of 40 book chapters and invited articles. He has also authored over 230 articles in peer-reviewed medical journals.
Dr. Thamer Alessa is Head of the Division of Endocrinology, Diabetes & Metabolism at Jaber Al-Ahmad Hospital and a Clinical Staff at Dasman Diabetes Institute in Kuwait. Received the bachelor’s degree of Medicine and Surgery form the University of Kuwait. Certified by the American Board of Internal Medicine after completing residency in Internal Medicine and fellowship in Endocrinology, Diabetes and Metabolism at the University of Miami, Jackson Memorial Hospital and Miami VA Hospital. Fellow of the American College of Endocrinology (FACE) and Certified Clinical Densitometrist (CCD). Vice President of the Kuwait Osteoporosis Society.
Dr. Alessa is Scientific Committee lead of the Kuwait Osteoporosis Society developing osteoporosis diagnosis and treatment protocol for general and family care physicians, 2018 and 2022. He was Coauthor of the consensus recommendation for the diagnosis and management of osteoporosis in postmenopausal women in Gulf Cooperation Council (GCC) countries, 2020
Additionally, Dr. Alessa was Cofounder for the development of the Primary Care Physicians Champions in OsteoPorosis ManagEment (HOPE) Program to improve knowledge and management of osteoporosis in primary care, Organizer for World Osteoporosis Day public events (2015-2021) and Organizer of several IOF Osteoporosis Essentials courses in Kuwait (clinicians and technologists tracks). He is a speaker and organizer and many local and international conferences in the field of osteoporosis diagnosis and management.
Rob Blank is Professor Emeritus of Medicine at the Medical College of Wisconsin and a Visiting Scientist at the Garvan Institute of Medical Research in Sydney, Australia. He is a past president of the ISCD and also served as chair of the science advisory committee and as a position development conference panelist.
Brenda McCarney, CBDT, RT(R) received a Radiologic Technologist Associate Degree from Madison College in Madison, Wisconsin. After working in Diagnostic Radiology she made the choice to work over 20 years solely for UW Health in the Bone Mineral Density department. Brenda co-authored an article “The Newly Recognized DXA Confounder: The Potassium Binding Medication Sodium Zirconium Cyclosilicate” in the Journal of Clinical Densitometry with Dr. Neil Binkley and Diane Krueger.